Quest Diagnostics Incorporated
DGX Healthcare Diagnostics & Research
Quest Diagnostics Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $11.0 billion, up 11.8% from fiscal 2024. In the quarter to June 2026, revenue grew 10.2%, EPS grew 14.7%, free cash flow grew 5.28% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years.
Follow DGX
Quest Diagnostics Incorporated (DGX) EPS (diluted)
Quest Diagnostics Incorporated's EPS (diluted) for fiscal 2025 was $8.75, up 13.8% from $7.69 in fiscal 2024. Over the twelve months to 30 June 2026 it was $9.42. Over the past ten years it has ranged from $4.51 (fiscal 2016) to $15.55 (fiscal 2021); the current reading is higher than 82% of that period. Quest Diagnostics Incorporated ranks 7th of 52 Diagnostics & Research companies by EPS (diluted).
EPS (diluted), annual
Embed this chart
Annual newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| FY2025 | $8.75 | 13.78% |
| FY2024 | $7.69 | 2.67% |
| FY2023 | $7.49 | (6.02%) |
| FY2022 | $7.97 | (48.75%) |
| FY2021 | $15.55 | 48.52% |
| FY2020 | $10.47 | 66.72% |
| FY2019 | $6.28 | 18.71% |
| FY2018 | $5.29 | (3.82%) |
| FY2017 | $5.50 | 21.95% |
| FY2016 | $4.51 | (7.39%) |
Quarterly newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| Jun 2026 | $2.84 | 26.79% |
| Mar 2026 | $2.24 | 2.75% |
| Dec 2025 | $2.18 | 0.93% |
| Sep 2025 | $2.16 | (12.55%) |
| 42 more quarters | Free account |
Against its own ten years
EPS (diluted) against peers
| Company | EPS (diluted) |
|---|---|
| MTD Mettler-Toledo International, Inc. compare | $44.43 |
| MEDP Medpace Holdings, Inc. compare | $17.06 |
| IDXX IDEXX Laboratories, Inc. compare | $14.22 |
| LH Labcorp Holdings Inc. compare | $12.09 |
| DGX Quest Diagnostics Incorporated | $9.42 |
| ILMN Illumina, Inc. compare | $5.36 |
| WAT Waters Corporation compare | $4.01 |
| RVTY Revvity Inc. compare | $2.10 |
| GH Guardant Health, Inc. compare | −$3.49 |
What EPS (diluted) is
Diluted EPS tells an investor how much profit a company earned for each share, counting the extra shares that options and convertible securities could create.
Reported line item
More on DGX
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement